Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Archives of General Psychiatry

• Publication date

  1988-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHPSYC.1988.01800340094019PMID 3262333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.

  1986cited by this paper
• A corticosteroid/dopamine hypothesis for psychotic depression and related states.

  1985cited by this paper
• Etiologic implications of corticosteroid changes in affective disorder.

  1985cited by this paper
• Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development.

  1982cited by this paper
• Ketoconazole blocks adrenal steroid synthesis.

  1982cited by this paper
• Dexamethasone induces tyrosine hydroxylase in sympathetic ganglia but not in adrenal medulla.

  1975cited by this paper
• CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS.

  1964cited by this paper
• Plasma cortisol in depressive illness.

  1962cited by this paper

• Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?

  2011cites this paper
• Hypothalamic–pituitary–adrenocortical system dysregulation and new treatment strategies in depression

  2009cites this paper
• Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

  2009cites this paper
• Antiglucocorticoids in psychiatry

  2009cites this paper
• Adrenal steroids and episodic memory: relevance to mood disorders

  2008cites this paper
• Depression: Chemical Mechanisms

  2008cites this paper
• Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression

  2007cites this paper
• Emerging treatments for major depression

  2007cites this paper
• Prospects for the Treatment of Depression

  2006cites this paper
• Antiglucocoticoid treatments for depression.

  2006cites this paper
• Psychotic Major Depression

  2006cites this paper
• Antiglucocoticoid Treatments for Depression

  2006cites this paper
• Can stress cause depression?

  2005cites this paper
• Steroids, neuroactive steroids and neurosteroids in psychopathology.

  2005cites this paper
• Hormones, Stress and Depression

  2005cites this paper
• Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

  2004cites this paper
• Hypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant Mice

  2004cites this paper
• Cortisol in Mood Disorders

  2004cites this paper
• Is the hypothalamic pituitary adrenal axis at last paying dividends

  2004cites this paper
• Can stress cause depression?

  2004cites this paper
• Effectiveness of antiglucocorticoid therapy in a patient with psychotic depression and ectopic ACTH production.

  2003cites this paper
• Challenges in the treatment of depression with psychotic features.

  2003cites this paper
• Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders.

  2002cites this paper
• Crossroads of corticotropin releasing hormone, corticosteroids and monoamines

  2002cites this paper
• Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

  2002cites this paper
• Double-Blind Antiglucocorticoid Treatment in Schizophrenia and Schizoaffective Disorder: A Pilot Study

  2002cites this paper
• Endocrine disturbances and psychiatric disorders

  2001cites this paper
• Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications

  2001cites this paper
• Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review.

  2001cites this paper
• Future therapeutic targets in mood disorders: the glucocorticoid receptor

  2000cites this paper
• Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression.

  2000cites this paper
• Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.

  2000cites this paper
• Antiglucocorticoid Medication for the Treatment of Depression: Theory and Current Practice

  2000cites this paper
• The specificity of stress responses to different nocuous stimuli: neurosteroids and depression.

  2000cites this paper
• Antiglucocorticoid treatment of depression: double-blind ketoconazole.

  1999cites this paper
• Limited efficacy of ketoconazole in treatment-refractory major depression.

  1999cites this paper
• Treatment of depression with antiglucocorticoid drugs.

  1999cites this paper
• Neuroendocrine Responses to Inhibitors of Steroid Biosynthesis in Patients with Major Depression Resistant to Antidepressant Therapy

  1998cites this paper
• Natural steroids counteracting some actions of putative depressogenic steroids on the central nervous system: potential therapeutic benefits.

  1997cites this paper
• The Relationship of Endogenous Cortisol to Psychiatric Disorder: A Review

  1997cites this paper
• Antiglucocorticoid treatments in psychiatry.

  1997cites this paper
• Antiglucocorticoid therapies in major depression: a review.

  1997cites this paper
• Geriatric endogenous cortisol psychosis--role of cortisol antagonists.

  1996cites this paper
• Antiglucocorticoids as Treatments for Depression

  1996cites this paper
• Management of psychotic, treatment-resistant depression.

  1996cites this paper
• Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration.

  1995cites this paper
• Prospects for improved antidepressants.

  1995cites this paper
• Involvement of corticosteroids in the processing of stressful life-events. A possible implication for the development of depression.

  1994cites this paper
• Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids.

  1994cites this paper
• Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.

  1993cites this paper
• The Pathophysiologic Significance of Hyperadrenocorticism: Antiglucocorticoid Strategies

  1993cites this paper
• Effects of adrenocortical steroids on long-term potentiation in the limbic system: Basic mechanisms and behavioral consequences

  1993cites this paper
• Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

  1993cites this paper
• Ketoconazole administration in hypercortisolemic depression.

  1993cites this paper
• Dexamethasone target sites in the central nervous system and their potential relevance to mental illness

  1993cites this paper
• Theoretical basis for response to steroid suppression in major depression.

  1992cites this paper
• The brain as a target for adrenocortical steroids: cognitive implications.

  1992cites this paper
• Antiglucocorticoid strategies in hypercortisolemic states.

  1992cites this paper
• Cognitive effects of corticosteroids.

  1990cites this paper